Re: "window".
Those who are proponents of Ivermectin claim there is a limited window to administer the drug for it to be effective. Meaning, it's administered early enough in the lifecycle so that its anti-viral replicating abilities who take effect.
Conversely, they claim studies claiming ivermectin's ineffectiveness was because it was given after said window.
Hence, my question wondering how many of those studies adhered to those parameters. Those that didn't, could, in theory, be dismissed if you are taking the pro-ivermectin side.
I think without looking through all the studies to ascertain where in the life cycle the drugs were started the burden of proof would rest in the pro-ivermectin camp to prove that there is a window at all. In other anti-viral trials we have established when they need to be taken and for them not to work when infection is active is extremely rare- in retro viruses etc.
They have conducted studies with folks who test positive without symptoms, which would be about as early as one could reasonable do it, folks that have been likely "exposed". The drug didnt reduce infection rates or severity. The drug does have some anti-inflammatory effects as well so there may be benefit to certain populaitons.
Overall, if it worked, we would have seen a signal in some of the studies, there wasn't once the quality of the studies improved.
So if what the studies are showing is incorrect, is the argument then that big pharma is suppressing ivermectin and if so, why? because they can't patent it?